142 related articles for article (PubMed ID: 2220578)
1. Effects of bepridil and diltiazem on ventricular repolarization in angina pectoris.
Funck-Brentano C; Coudray P; Planellas J; Motté G; Jaillon P
Am J Cardiol; 1990 Oct; 66(10):812-7. PubMed ID: 2220578
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group.
Singh BN
Am J Cardiol; 1991 Aug; 68(4):306-12. PubMed ID: 1858672
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
Frishman WH
Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
[TBL] [Abstract][Full Text] [Related]
4. Bepridil treatment of chronic stable angina: a review of comparative studies versus placebo, nifedipine, and diltiazem.
DiBianco R
Am J Cardiol; 1992 Apr; 69(11):56D-62D. PubMed ID: 1532468
[TBL] [Abstract][Full Text] [Related]
5. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.
Hollingshead LM; Faulds D; Fitton A
Drugs; 1992 Nov; 44(5):835-57. PubMed ID: 1280569
[TBL] [Abstract][Full Text] [Related]
6. Bepridil hydrochloride compared with placebo in patients with stable angina pectoris.
Narahara KA; Singh BN; Karliner JS; Corday SR; Hossack KF
Am J Cardiol; 1992 Apr; 69(11):37D-42D. PubMed ID: 1553890
[TBL] [Abstract][Full Text] [Related]
7. Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil.
Yoshiga Y; Shimizu A; Yamagata T; Hayano T; Ueyama T; Ohmura M; Itagaki K; Kimura M; Matsuzaki M
Circ J; 2002 Nov; 66(11):1024-8. PubMed ID: 12419934
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of bepridil versus placebo in angina pectoris: treatment and withdrawal studies.
Shapiro W
Am J Cardiol; 1992 Apr; 69(11):43D-49D. PubMed ID: 1553891
[TBL] [Abstract][Full Text] [Related]
9. Circadian and power spectral changes of RR and QT intervals during treatment of patients with angina pectoris with nadolol providing evidence for differential autonomic modulation of heart rate and ventricular repolarization.
Sarma JS; Singh N; Schoenbaum MP; Venkataraman K; Singh BN
Am J Cardiol; 1994 Jul; 74(2):131-6. PubMed ID: 8023776
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
Shapiro W; DiBianco R; Thadani U
Am J Cardiol; 1985 Mar; 55(7):36C-42C. PubMed ID: 3919556
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bepridil with nadolol for angina pectoris.
Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of drug-induced QT interval modifications in dynamic electrocardiography: the case of bepridil.
Coumel P; Leclercq JF; Naditch L; Pellerin D
Fundam Clin Pharmacol; 1993; 7(1):61-8. PubMed ID: 8458603
[TBL] [Abstract][Full Text] [Related]
13. Long-term bepridil monotherapy for angina pectoris.
Sharma MK; Voyles W; Prasad R; Teague SM; Thadani U
Am J Cardiol; 1988 Jun; 61(15):1210-3. PubMed ID: 3287882
[TBL] [Abstract][Full Text] [Related]
14. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs].
Sellier P; Quilliet L
Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):602-8. PubMed ID: 9538375
[TBL] [Abstract][Full Text] [Related]
16. Effects of bepridil and CERM 4205 (ORG 30701) on the relation between cardiac cycle length and QT duration in healthy volunteers.
Lecocq B; Lecocq V; Prost PL; Fleurot O; Boisson P; Jaillon P
Am J Cardiol; 1990 Sep; 66(5):636-41. PubMed ID: 2203243
[TBL] [Abstract][Full Text] [Related]
17. Effects of bepridil on the resting electrocardiogram.
Hill JA; Pepine CJ
Int J Cardiol; 1984 Sep; 6(3):319-23. PubMed ID: 6384070
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum bepridil concentration and corrected QT interval.
Matsui K; Mukai Y; Sakakura K; Wada K; Nakamura T; Kawabata A; Terakawa N; Hayakawa N; Kusano K; Hosomi K; Yokoyama S; Takada M
Int J Clin Pharmacol Ther; 2021 Jan; 59(1):63-70. PubMed ID: 33026317
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the mid-term electrocardiographic and clinical tolerability of bepridil versus diltiazem in patients with coronary disease].
Puech P; Coumel P; Maison Blanche P; Coudray P
Ann Cardiol Angeiol (Paris); 1990 Sep; 39(7):437-42. PubMed ID: 2264710
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States.
Singh BN
Am J Cardiol; 1992 Apr; 69(11):68D-74D. PubMed ID: 1532469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
